Clinical Trials Browser

OTHER × Neoplasm Metastasis × sintilimab × Clear all

NCT05472948 2025-12-17

Surufatinib and Sintilimab in Combination With Capecitabine for Metastatic Adenocarcinoma of Small Intestine or Appendix Carcinoma

Phase 2 Recruiting

Gastrointestinal

Appendiceal Neoplasms, Neoplasm Metastasis

NCT04398927 2021-02-04

Systemic Chemotherapy Plus PD-1 for Metastasis ICC

Phase 2 Withdrawn

Neoplasm Metastasis